Computational Biology Market

According to IMARC Group latest report titled “Computational Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on computational biology market share. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global computational biology market size reached US$ 4.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.24 Billion by 2028, exhibiting a growth rate (CAGR) of 21.3% during 2023-2028.

Computational biology is a field at the intersection of biology and computer science that utilizes advanced computational techniques and algorithms to analyze and interpret biological data. It involves the development and application of computational models, simulations, and data analysis tools to understand complex biological processes, and predict protein structures and functions. Computational biology plays a crucial role in accelerating scientific research, enabling the discovery of new drugs and therapies, and advancing personalized medicine. By employing computational algorithms, machine learning, and big data analytics, computational biology offers a multidisciplinary approach to understanding the human body.

Request to Get the Sample Report: https://www.imarcgroup.com/computational-biology-market/requestsample

Market Trends:

The global computational biology market is primarily being driven by the increasing demand for personalized medicine and targeted therapies. With the ability to analyze vast amounts of genomic and clinical data, computational biology enables researchers and healthcare professionals to develop tailored treatment plans based on an individual's genetic makeup, improving treatment efficacy and patient outcomes. Furthermore, the rising focus on drug discovery and development has driven the demand for computational biology solutions. The ability to simulate drug interactions, predict toxicity, and optimize drug design using computational models and simulations significantly accelerates the drug discovery process, reducing costs and increasing success rates.

Additionally, the advent of high-throughput technologies, such as next-generation sequencing and omics technologies, has generated massive amounts of biological data, creating a need for sophisticated computational tools to analyze and extract meaningful insights from these datasets. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) algorithms in computational biology has revolutionized the field, enabling the discovery of novel biomarkers, identification of disease patterns, and prediction of treatment responses. The market is also witnessing the emergence of cloud-based computational biology platforms, offering scalability, flexibility, and collaborative capabilities to researchers and organizations. Lastly, the growing emphasis on bioinformatics and genomics research in academic institutions and the pharmaceutical industry has propelled the demand for computational biology solutions, thereby accelerating the market growth.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/computational-biology-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Certara

• Chemical Computing Group ULC

• Compugen Ltd

• Dassault Systèmes

• Genedata AG

• Insilico Biotechnology AG

• Instem plc

• Nimbus Therapeutics LLC

• Schrödinger Inc.

• Simulations Plus Inc

Computational Biology Market Segmentation:

Our report has categorized the market based on region, application, services and end use industry.

Breakup by Application:

• Cellular and Biological Simulation

  • Computational Genomics

  • Computational Proteomics

  • Pharmacogenomics

  • Others

• Drug Discovery and Disease Modelling

  • Target Identification

  • Target Validation

  • Lead Discovery

  • Lead Optimization

• Preclinical Drug Development

  • Pharmacokinetics

  • Pharmacodynamics

• Clinical Trials

  • Phase I

  • Phase II

  • Phase III

• Human Body Simulation Software

Breakup by Services:

• In-house

• Contract

 Breakup by End Use:

• Academics

• Pharmaceutical Industry

• Commercial

Breakup by Region:

• North America (United States, Canada)

• Europe (Germany, France, United Kingdom, Italy, Spain, Others)

• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance (2017-2022)

• Market Outlook (2023-2028)

• Porter’s Five Forces Analysis

• Market Drivers and Success Factors

• SWOT Analysis

• Value Chain

• Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800